AstraZeneca has had a setback in its late-stage oncology pipeline, after AKT inhibitor ceralasertib, given in combination with cancer immunotherapy Imfinzi, failed to extend survival in a lung cancer ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Colleen Hagerty Colleen Hagerty is a writer focused on emergency preparedness.
HSBC became the first major lender to reduce mortgage costs for 2026 on Monday, cutting prices across a wide range of deals including for first-time buyers, landlords and remortgagers, writes Laura ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback